COVID-19 Vaccines and Infections

Currently, there is a very small number of Americans that have gained immunity from vaccination trials.  The FDA would probably approve the Pfizer vaccine by Dec 10th and the Moderna one by Dec. 20th.  By the end of this year, Pfizer and Moderna would have supplied enough vaccines to permit 20M Americans to have had their first shot.  By early next year, 19M Americans would have gained immunity from these two shot vaccines (taking into account the current estimated 95% effectiveness of these vaccines).  Many people estimate that enough vaccine would be available to vaccinate 25M-30M Americans every month in 2021 subject to logistical and psychological constraints (deep blue area in the graph below).  Thus vaccine “herd immunity threshold = 230M” could be reached in the USA by the end of summer. 

Herd immunity could actually be reached sooner than that.  Currently over 14M Americans have gained immunity from being infected by SARS-Cov-2.  The immunity may not be perfect but seems to be at least 99% effective for 6 months.  We project that by yearend 19.5M Americans will have tested positive for COVID-19 (red area).  Due to testing bottlenecks and scarcity, there is a hidden population of asymptomatic and mildly symptomatic cases that we estimate to be twice as big as confirmed cases for a total of 42M currently immune and 55M immune by yearend (red+green areas).  The total infected has been estimated to be as high as 8x by the CDC or 111M currently (red+green+purple areas).  We consider this to be highly unlikely for the USA as a whole even though antibody surveys for small sections of the USA have ranged from 2x to 20x the confirmed population.  If we adopt our best guess estimate for total immunity, we project that it will exceed the threshold for herd immunity by mid-year and stop exponential growth in the USA.     

The CDC has established guidelines for prioritizing vaccinations among different groups of people (healthcare workers, and residents of long-term care facilities). But they omitted to spell out who in those groups should be vaccinated first.  In fact, we believe that everyone should be tested for antibodies before they are vaccinated.  This would allow scientists to:

1.    optimize the distribution of an initially scarce vaccine to those who really need it,

2.    provide a baseline and periodic retests to measure how effectively these new vaccines are producing antibodies

3.   provide us with detailed measures of the true population of infectees.

Comments

Post a Comment

Popular posts from this blog

COVID-19 Infection and Mortality Rates as a Function of Age and Gender

Image
With over 2.4 million COVID-19 cases and over 160,000 deaths globally, there is a lot of data that can be analyzed to better understand this virus as a function of age, co-morbidities, medical history (such as prior exposure to coronaviruses like SARS, and other vaccines like BCG), etc.   The two important factors that have been noted since the early days of this pandemic are age and gender and they continue to be the most important factors.   We look at the age and gender dependencies with the best single data set provided by the Spanish Health Department containing over 200,000 cases (or 0.4% of the total population) and over 20,000 deaths.   Spain has tested over 2.0% of its population which while short of a comprehensive sample does begin to give us some ideas about how the disease has affected the entire country.   We look at the probability of a random person acquiring the disease as a function of age.   We know that this sample is not truly random no...
Read more

COVID-19 is now officially a Pandemic

The WHO after many weeks of dithering has finally declared COVID-19 a pandemic.   Most scientists and healthcare professionals already had been treating it as such anyway.   Scientific advisers to Chancellor Merkel warned her that as many as 2/3 of all Germans may contract the coronavirus and she needed to attack it seriously and immediately as a major pandemic.   The US, as many had urged for weeks, is finally ramping up testing and found 313 new cases today – more than the cumulative total for weeks up to March 5 th .   The stock market took another major tumble today with the Dow now down more than 20% - forecasting a recession is coming to the US.   (These forecasts are sometimes scoffed at since the Dow has forecast 9 of the past 5 recessions.)   Is the world ending?   Is there any good news? I think the risks are many and they are far more likely than optimistic scenarios painted by Trump, but there are some signs that the world may av...
Read more

Pre-Thanksgiving Dip in COVID-19 Cases

Image
COVID-19 cases in the USA have shown a sharp decrease over the last 8 days causing the 7-day rolling average to peak and rollover (see figure below – red squares).   The question is whether this is measuring a real lasting phenomenon – perhaps attributable to local COVID-19 fires burning out, or to mitigation factors taking hold, or to some temporary factor associated with the Thanksgiving holiday.   The answer is probably a combination of all three that will ultimately be overwhelmed by an increase in Thanksgiving transmission. Some COVID-19 outbreaks have burned so strongly and for so long (3-4 months) that local “herd immunity” may be acting as a retardant to the fire.   For example, in North Dakota (ND) 10.3% of the population has now been confirmed infected (see table below).   State Confirmed Testing Est. Pop Deaths Death per Fatality   Infection % Positive % ...
Read more